Themis Medicare Ltd.
NSE: THEMISMED | BSE: 530199
₹118.20
₹-3.05
(-2.52%)
As on 24-Jun-2026IST
Market cap
₹1,087 Cr
Revenue (TTM)
₹342 Cr
P/E Ratio
950
P/B Ratio
3
Div. Yield
0.4 %
Quality Score
2/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
7.6 %
-
ROCE
10.4 %
-
Industry P/E
45.19
-
EV/EBITDA
120.7
-
Debt to Equity
0.1
-
Book Value
₹39.7
-
EPS
₹0.3
-
Face value
1
-
Shares outstanding
92,100,120
10 Years Aggregate
CFO
₹207.62 Cr
EBITDA
₹446.12 Cr
Net Profit
₹289.22 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Themis Medicare
| 17.5 | 17.9 | 66.2 | -11.3 | -4.6 | 10.9 | 8.3 |
|
BSE Healthcare
| 11.9 | 2.8 | 17.6 | 12.9 | 25.0 | 14.3 | 12.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Themis Medicare
| -61.9 | 19.9 | 57.7 | 43.5 | 162.3 | 8.6 | -3.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Themis Medicare
|
118.2 | 1,086.8 | 342.2 | -12.9 | -2.9 | 0.8 | 950 | 3.0 |
| 3,268.6 | 26,669.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 74.9 | 16.1 | |
| 462.4 | 17,372.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 96.9 | 4.4 | |
| 770.9 | 19,144.8 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.2 | 3.8 | |
| 972.8 | 15,481.3 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38.8 | 2.2 | |
| 893.6 | 16,095.7 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.3 | 1.7 | |
| 1,564.0 | 18,084.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.1 | |
| 172.4 | 22,553.0 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 443.0 | 17,789.7 | 3,738.7 | 316.7 | 12.5 | 7.5 | 56.2 | 3.7 | |
| 1,968.3 | 32,239.3 | 3,373.0 | 199.0 | 12.6 | 5.9 | 151.4 | 6.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Themis Medicare
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including... anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, hematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasodilator, vasopressors, and vitamins. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is based in Mumbai, India. Read more
-
Incorporated
1969
-
Chairman
Dinesh S Patel
-
Managing Director
Sachin D Patel
-
Headquarters
Vapi, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Themis Medicare
What is the current share price of Themis Medicare Ltd Today?
The share price of Themis Medicare Ltd is ₹118.20 (NSE) and ₹118.25 (BSE) as of 24-Jun-2026 IST. Themis Medicare Ltd has given a return of -4.59% in the last 3 years.
What is the current PB & PE ratio of Themis Medicare Ltd?
The P/E ratio of Themis Medicare Ltd is 949.98 times as on 24-Jun-2026, a 2002 premium to its peers’ median range of 45.19 times.
The P/B ratio of Themis Medicare Ltd is 2.97 times as on 24-Jun-2026, a 33 discount to its peers’ median range of 4.43 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
45.24
|
3.35
|
|
2024
|
46.31
|
5.34
|
|
2023
|
1.89
|
3.16
|
|
2022
|
1.18
|
2.99
|
|
2021
|
0.72
|
1.18
|
What is the 52 Week High and Low of Themis Medicare Ltd?
The 52-week high and low of Themis Medicare Ltd are Rs 148.00 and Rs 64.95 as of 24-Jun-2026.
What is the market cap of Themis Medicare Ltd?
Themis Medicare Ltd has a market capitalisation of ₹ 1,087 Cr as on 24-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Themis Medicare Ltd?
Before investing in Themis Medicare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.